Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)
Conditions: NVP Plasma Level; NVP Related Mutation; 3TC Related MutationIntervention: Drug: AZT/3TC 2 weeks after deliverySponsors: Thai Red Cross AIDS Research Centre; Chulalongkorn University; Queen Savang Vadhana Memorial Hospital, ThailandRecruiting - verified September 2009
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials